Risofos 35mg Tabs 4’s

Risofos 35mg Tabs 4’s — Reglutide (Semaglutide 1.34 mg/ml) is a glucagon-like peptide-1 (GLP-1) receptor agonist used primarily for the treatment of type 2 diabetes mellitus and chronic weight management. It is administered via subcutaneous injection.

Ingredients:
Brand Name: Reglutide SC Injection
Active Ingredient: Semaglutide 1.34 mg/ml
Manufacturer: Beximco Pharmaceuticals Ltd
Formulation: 3 ml cartridge with device

Benefits:
Diabetes Management: Improves glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Cardiovascular Risk Reduction: Reduces the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.
Weight Management: Supports chronic weight management in adults with a BMI of ≥30 kg/m² (obesity) or ≥27 kg/m² (overweight) with at least one weight-related comorbidity.

How to use:
Diabetes:
Start with 0.25 mg once weekly, increase to 0.5 mg after 4 weeks, and up to 1 mg weekly for further control.
Obesity: Start with 0.25 mg once weekly for 4 weeks, increase to 0.5 mg, and eventually to 2.4 mg weekly. Adjust as tolerated.
Administration: Inject subcutaneously in the abdomen, thigh, or upper arm. Do not inject intravenously or intramuscularly. Always use as directed by your healthcare professional and follow a balanced diet for best results.